摘要 ： 市场监管总局启动《检验检测机构监督管理办法》修订工作，现向社会公开征求意见，意见反馈截止日期为2025年10月28日 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 为深入贯彻落实党中央、国务院决策部署，进一步强化检验检测行业管理，规范检验检测市场秩序，促进行业持续健康发展，市场监管总局启 动《检验检测机构监督管理办法》修订工作，组织起草了《检验检测机构监督管理办法（征求意见稿）》，现向社会公开征求意见。公众可通 过以下途径和方式提出意见： 一、登录市场监管总局网站（网址：http: / /www. samr.gov .cn），通过首页"互动"栏目中的"征集调查"提出意见。 二、通过电子邮件将意见发送至：r k jcs jgc@samr.gov .cn。邮件主题请注明"检验检测机构监督管理办法公开征求意见"字样。 三、通过信函将意见邮寄至：北京市海淀区马甸东路9号，市场监管总局认可检测司（邮政编码100088）。信封上请注明"检验检测机构监督 管理办法公开征求意见"字样。 意见反馈截止日期为2025年10月28日。 | | 验检测 ...

Core Viewpoint - The company, Guangdian Jiliang, has responded to regulatory inquiries regarding its fundraising plans and the high levels of accounts receivable, emphasizing the necessity and rationale behind its investment projects aimed at expanding and upgrading its existing business capabilities [1][2][4]. Fundraising and Investment Projects - Guangdian Jiliang plans to raise up to 1.3 billion yuan through the issuance of no more than 67.13 million shares, targeting projects in aviation equipment testing, AI chip testing, and satellite internet quality assurance [1]. - The company asserts that the fundraising projects are not duplicative investments but rather enhancements to existing services, focusing on strategic emerging fields [3][4]. Accounts Receivable Concerns - The company's accounts receivable have been a focal point for regulators, with values reported at 1.202 billion yuan, 1.274 billion yuan, 1.328 billion yuan, and 1.375 billion yuan for the years 2022, 2023, 2024, and the first half of this year, respectively [1][2]. - Accounts receivable accounted for over 45% of current assets in the latest reporting period, with a turnover rate of only 0.46 times [1][2]. Client Classification and Payment Terms - The company categorizes clients into three groups (A, B, C) based on transaction size and payment history, with a significant portion of accounts receivable attributed to government and special industry clients, which typically have longer payment cycles [2]. - The company indicates that the high proportion of accounts receivable relative to revenue is due to the time required for clients to settle payments after receiving inspection reports [2]. Capacity and Market Position - Guangdian Jiliang claims its current capacity utilization is above the industry average, necessitating further investment to enhance competitiveness and meet market demands [4]. - The company has secured substantial orders for its new testing platforms, indicating a strong pipeline to support future revenue growth [5]. Previous Fundraising and Project Adjustments - In May 2021, the company raised 1.486 billion yuan for various projects, but some of these have been delayed until 2025 due to market conditions and operational assessments [5][6]. - The company has reallocated unspent funds from previous projects to new initiatives aimed at expanding its business coverage in the central region of China [6].

Group 1 - The core viewpoint of the news is that Lianjian Technology has shown a mixed performance in its stock price and financial results, with a notable increase in revenue and net profit year-on-year [1][2]. - As of September 24, Lianjian Technology's stock price increased by 2.05% to 15.92 CNY per share, with a total market capitalization of 2.948 billion CNY [1]. - The company has experienced a year-to-date stock price increase of 16.61%, but has seen a decline of 3.16% in the last five trading days [1]. Group 2 - For the first half of 2025, Lianjian Technology achieved operating revenue of 641 million CNY, representing a year-on-year growth of 7.93%, and a net profit attributable to shareholders of 24.91 million CNY, up 37.75% year-on-year [2]. - The company has distributed a total of 253 million CNY in dividends since its A-share listing [3]. - The main business revenue composition includes inspection and testing services at 70.09%, sales of new engineering materials at 15.35%, and special engineering services at 14.31% [1].

Core Viewpoint - Shanghai Feilo Acoustics Co., Ltd. experienced a significant stock price fluctuation, with a cumulative increase of 20% over three consecutive trading days from September 16 to September 18, 2025, indicating abnormal trading activity [2][4]. Stock Trading Abnormality - The company's stock price deviation reached a cumulative increase of 20% over three trading days, qualifying as abnormal trading according to Shanghai Stock Exchange rules [4]. - The stock turnover rate on September 18, 2025, was 6.05%, and the stock volatility was 8.53%, suggesting potential irrational speculation [3]. Company Operations and Financials - The company confirmed that its production and operations are normal, with no significant changes expected in the internal or external business environment [5]. - As of September 17, 2025, the company's rolling price-to-earnings (P/E) ratio was 463.50, significantly higher than the industry average P/E ratio of 24.51, indicating a high valuation risk [3]. Major Events and Disclosures - The company and its controlling shareholder, Shanghai Yidian Electronics (Group) Co., Ltd., reported no undisclosed significant matters, including major asset restructuring or share issuance [6]. - There were no media reports or market rumors that could have influenced the stock price during the abnormal trading period [7]. - The company’s major shareholder, Shanghai Lingang Economic Development (Group) Co., Ltd., has a share reduction plan but did not sell shares during the recent stock price increase [9]. Investor Communication - The company held a half-year performance briefing on September 18, 2025, where management addressed investor concerns regarding future strategies and operational changes [14][15]. - The company aims to become a leading provider of smart hardware and industrial intelligent solutions, focusing on core business areas such as smart hardware products and testing services [18].

Core Viewpoint - The company, Feilo Acoustics (600651), held a performance briefing on September 18, 2023, and clarified its strategic direction, indicating no plans to enter the lithography machine sector or engage in significant asset restructuring or injection activities [1] Group 1: Business Overview - The company's core business consists of three main segments: smart hardware products, solutions, and inspection and testing [1]

Core Viewpoint - The company announced that it has no plans to enter the lithography machine sector or engage in significant asset restructuring or injection activities, focusing instead on becoming a leading provider of smart hardware and industrial intelligent solutions [1] Group 1: Company Strategy - The company aims to become a leading provider in the smart hardware and industrial intelligent solutions market [1] - The core business segments include smart hardware products, solutions, and inspection and testing [1]

Group 1 - The core viewpoint of the news is that Lianjian Technology has shown a positive performance in terms of stock price and financing activities, indicating potential investor interest and market confidence [1][2]. - On September 11, Lianjian Technology's stock price increased by 1.09%, with a trading volume of 48.48 million yuan. The net financing purchase on that day was 877,500 yuan, with a total financing and securities balance of 37.07 million yuan, which is 1.69% of the circulating market value [1]. - The financing balance is currently low, below the 20th percentile level of the past year, while the securities lending balance is at a high level, exceeding the 90th percentile of the past year [1]. Group 2 - As of June 30, Lianjian Technology had 21,600 shareholders, an increase of 0.87% from the previous period, with an average of 4,892 circulating shares per person, a decrease of 0.86% [2]. - For the first half of 2025, Lianjian Technology achieved an operating income of 641 million yuan, representing a year-on-year growth of 7.93%, and a net profit attributable to the parent company of 24.91 million yuan, up 37.75% year-on-year [2]. - Since its A-share listing, Lianjian Technology has distributed a total of 253 million yuan in dividends [3].

Core Insights - The article highlights the importance of inspection and testing as a core component of the national quality infrastructure, emphasizing its role in fostering new industries, models, and dynamics [1] Group 1: Industry Developments - The State Administration for Market Regulation has established over 1,200 public service platforms for inspection and testing, addressing more than 20,000 product quality issues [1] - A total of 874 national quality inspection centers are planned to be built, providing high-end inspection and testing services for emerging industries [1] Group 2: Future Directions - In response to new opportunities and challenges in the era of artificial intelligence, the State Administration for Market Regulation will guide inspection and testing institutions to deeply participate in creating an innovative hub for AI inspection and testing [1] - There is a focus on constructing an intelligent testing standard system and fostering cross-field industrial collaborative innovation communities [1]

Group 1 - Chengdu Meinian Medical Laboratory Co., Ltd. has been established with a registered capital of 10 million yuan [1] - The business scope includes inspection and testing services, operation of Class III medical devices, development of human genetic diagnosis and treatment technology, and information system integration services [1] - The company is wholly owned by Meinian Health (002044) through indirect shareholding [1]

Group 1 - The company, Zhongji Renjian (301508), is a national third-party certification and inspection service provider for vehicles and machinery equipment [1] - The company has announced its capability to conduct environmental adaptability tests and electromagnetic compatibility (EMC) testing specifically for industrial robots [1]